Ameritas Investment Partners, Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$134,652
+10.4%
4,884
+20.3%
0.01%0.0%
Q2 2023$122,014
-10.6%
4,059
+7.8%
0.01%0.0%
Q1 2023$136,442
-12.0%
3,7660.0%0.01%
-16.7%
Q4 2022$155,084
+22.1%
3,7660.0%0.01%0.0%
Q3 2022$127,000
+17.6%
3,7660.0%0.01%
+20.0%
Q2 2022$108,000
-11.5%
3,7660.0%0.01%
+25.0%
Q1 2022$122,000
+10.9%
3,7660.0%0.00%0.0%
Q4 2021$110,000
+10.0%
3,7660.0%0.00%0.0%
Q3 2021$100,000
-21.3%
3,766
-8.7%
0.00%
-20.0%
Q2 2021$127,000
+17.6%
4,1230.0%0.01%
+25.0%
Q1 2021$108,000
-2.7%
4,123
-6.7%
0.00%
-20.0%
Q4 2020$111,000
+20.7%
4,4180.0%0.01%
+25.0%
Q3 2020$92,000
-12.4%
4,4180.0%0.00%
-20.0%
Q2 2020$105,000
+32.9%
4,4180.0%0.01%
+25.0%
Q1 2020$79,000
-18.6%
4,418
+8.2%
0.00%0.0%
Q4 2019$97,000
-13.4%
4,0820.0%0.00%
-20.0%
Q3 2019$112,000
-17.0%
4,0820.0%0.01%
-16.7%
Q2 2019$135,000
-5.6%
4,0820.0%0.01%
-14.3%
Q1 2019$143,000
+5.1%
4,0820.0%0.01%0.0%
Q4 2018$136,000
-34.0%
4,0820.0%0.01%
-30.0%
Q3 2018$206,000
-15.6%
4,0820.0%0.01%
-16.7%
Q2 2018$244,000
+31.2%
4,082
+0.8%
0.01%
+33.3%
Q1 2018$186,000
+15.5%
4,0510.0%0.01%
+28.6%
Q4 2017$161,000
-13.0%
4,0510.0%0.01%
-22.2%
Q3 2017$185,000
+5.7%
4,0510.0%0.01%
+12.5%
Q2 2017$175,000
+37.8%
4,0510.0%0.01%
+33.3%
Q1 2017$127,0004,0510.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders